bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: D N O S A J J M A M F J
2016: D

 
  Other news for:
Diabetes Mellitus
Diabetes Mellitus, Non-Insulin-Dependent
 Resources from HONselect
Ozempic Approved for Type 2 Diabetes

By Scott Roberts

WEDNESDAY, Dec. 6, 2017 (HealthDay News) -- Ozempic (semaglutide) has been approved by the U.S. Food and Drug Administration as a weekly injection to treat type 2 diabetes in adults.

More than 28 million people in the United States have type 2 diabetes, which occurs when the body can no longer produce the sugar-regulating hormone insulin, or the body can't use insulin properly.

People with type 2 diabetes are two to four times more likely than the average person to develop heart disease, said Novo Nordisk, the maker of the drug.

In clinical trials involving more than 8,000 adults with type 2 diabetes, Ozempic was shown to help users lower A1c, a test that measures the amount of glucose in a person's blood. The drug, when combined with proper diet and exercise, also was shown to help users lose weight, Novo said in a company news release.

The drug's most common side effects include nausea, vomiting, diarrhea, abdominal pain and constipation. Less common but more serious adverse reactions could include thyroid tumors, pancreatitis, changes in vision, kidney failure and serious allergic reactions, the Plainsboro, N.J.-based company said.

As a condition of approval, the FDA is requiring Novo to study the drug's safety and effectiveness in people under 18.

More information

Novo Nordisk has more about this approval.

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=729152

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Adult
Thyroid Gland
Hypersensitivity
Heart
Blood
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Inicio img Sobre nosotros img Rincón de la prensa img Boletín HON img Mapa del sitio img Política ética img Contactos